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I.

Introduction

York County, the second most populated County in Maine with an estimated population
of 204,191 (US Census 2017), has been greatly affected by the Opioid crisis. Opioids are
prescription medications used to treat or relieve pains. They act by binding to specific receptors
in the brain, spinal cord and gastrointestinal tract to reduce pain and can have other effects such
as altering moods, decreased breathing and cause euphoria (SAMHSA, 2015). Synthetic opioids
(other than methadone) are currently the main driver of drug overdose deaths (CDC, 2018)
nationally and in Maine. The opioid crisis began in the 1990’s when physicians over prescribed
opioids for pain relief without knowledge of the additive effect. The consequence of this over
prescription coupled with the proliferation of illicitly manufactured drugs has led to a rise in
Opioid Use Disorder (OUD) (HHS fact sheet, 2019).
Currently, York Public Health District has the third highest drug/medication overdose
responses and the highest drug related arrests and violent crimes when compared to other public
health districts in Maine (Maine SEOW, 2018). Consequently, the number of opioid related
deaths in York County has increased over the years with 79 deaths occurring between 2007-2011
and 166 deaths occurring between 2012-2016 (NORC, 2017). Also, opioid mortality rate is
estimated at 28.4 per 100,000 people which is higher than the estimated 22.5 per 100,000 people
in Maine and 14.1 per 100,000 people in the US (NORC, 2017).
Medicated Assisted Treatment (MAT) combines the use of medications with counselling
and behavioral therapy, is an effective evidence-based treatment for OUD. The medications work
by blocking the euphoric effects of opioids and relieving physiological cravings to normalize the
brain and body functions (SAMHSA, 2015).
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There are three FDA approved drugs used to treat OUD, these include: methadone (opioid
agonist), Naltrexone (non-addictive opioid antagonist) and Buprenorphine (opioid
agonist/antagonist). These drugs are highly regulated and require providers to obtain training and
waivers to prescribe them. Methadone can only be prescribed in methadone clinics by waivered
providers working in clinics approved to be opioid treatment programs, buprenorphine is
prescribed by providers who get DEA waivers while Naltrexone, can be prescribed by any
licensed health provider. Similarly, another important medication is Naloxone an FDA approved
drug which is mainly used during an overdose emergency to reverse the effects of opioids
(SAMHSA, 2015) and are also prescribed by providers to high risk OUD patient.

Description of Problem
As of 2018, York County remains designated as a Health Professional Shortage Area and
a Medically Underserved Area/Population with 0.32 providers per 1,000 population (HRSA Fact
Sheet-FY 2018 York, Maine). This inadequate provider workforce makes accessing treatment
for OUD difficult in York County. In addition, there are only 26 providers (including 4 Nurse
Practitioners) certified to provide buprenorphine treatment (SAMHSA, 2019). This does not
meet the demands for OUD treatment especially with evidence that shows that most waivered
providers are prescribing to less patients allowed by regulation (Andrilla, et al 2019).
To address provider shortage and limited treatment infrastructure in York County,
Southern Maine Health Care (SMHC) partnered with Nasson Health Care, Maine Behavioral
Healthcare (MBH), Frannie Peabody Center (FPC), North East Mobile Health Services
(NEMHS) and the Kennebunk Police Department (KPD) to obtain funding from HRSA to
support a comprehensive strategic planning process designed to improve the current model of
care available for treatment of OUD. The goal of the project is to strengthen the current
3
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infrastructure in rural communities in York County to ensure the provision of comprehensive
prevention, treatment and recovery services to reduce opioid related morbidity and mortality.

II.

Literature Review

The Drug Addiction Treatment Act of 2000 (DATA 2000), permits qualified physicians
to obtain a waiver from the separate registration requirements of the Narcotic Addict Treatment
Act – 1974 to treat opioid dependency with Schedule III, IV, and V medications or combinations
of such medications that have been approved by FDA for that indication. To obtain waivers,
physicians must complete 8 hours of required training (24 hours for nurse practitioners and
physician assistants) to become qualified to prescribe to a maximum of 30 patients with OUD.
The limit can be increased to 100 and then to 275 after at least one year of initial approval
(SAMHSA). The DEA list shows that since 2012, the MAT workforce has increased nationwide
because of the inclusion of nurse practitioners and physician assistants with 45.9% and 24.5% of
urban counties having a waivered NP or PA respectively and 13.8% and 4.6% of rural counties
having a waivered NP or PA respectively. Despite the increase in waivered providers, MAT
remains largely under-utilized with many waivered providers not offering MAT services or
limiting the size of their MAT patient panel (Andrilla et al, 2019). The proportion of heroin
admissions with treatment plans that included receiving medication-assisted opioid therapy fell
from 35% in 2002 to 28% in 2010 (SAMHSA’s Treatment Episode Data Set (TEDS) 2002-2010)
highlighting the under prescription of MAT. Among providers, there are many barriers to
implementing MAT for OUD in their clinical practice including: inadequate training, lack of
institutional and clinical peer support, poor care coordination, complex insurance requirements,
low reimbursements, burdensome regulatory process and providers stigma (Storholm et al 2017,
Jones et al 2019 and Haffajee et al 2018).
4
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Treatment/ Encounters of OUD by Provider Type
Emergency Department (ED) Providers:
The ED sees a high volume of individuals experiencing opioid related overdoses and
Opioid Withdrawal (OW) cases. From July 2016 through September 2017, a total of 142,557 ED
visits suspected to be opioid-involved overdoses (15.7 per 10,000 visits) were reported across 45
states of the US, with Maine reportedly having a significant quarterly rate increases from third
quarter 2016 to third quarter 2017 (Vivolo-Kantor et al, 2018). In the ED, Buprenorphine
administration can be done by any licensed provider without further certification. The ED plays
an important role in the initiation and sustenance of MAT when OUD is identified in patients
since ED physicians are obligated to intervene by initiating Buprenorphine treatment (Cisewski
et al, 2018). There is evidence that ED-initiated Buprenorphine treatment is associated with
increased engagement in outpatient treatment programs and reduced illicit drug use (D'Onofrio et
al 2017). However, some views of Buprenorphine as a substitution for another drug is a common
barrier in its utilization in the ED (Cisewski et al, 2018) and is underutilized in EDs (Larochelle
et al, 2017). Cisewski et al, 2018 suggest that providing patient from the ED with outpatient
multimodal medication-assisted treatment (MAT) clinic information for planned follow up
within 48-72H is a critical component of such ED encounters.
Primary Care Providers:
Primary care settings are an important entry point for patient suffering from various
chronic disease including OUD and with the wealth of medical and behavioral information
available for diagnosis, it is the ideal place to integrate MAT if adequate organizational support
is in place to support providers (Mannelli and Wu, 2016). The number of primary care providers
with DEA waivers to prescribe MAT has increased across the US, especially with the inclusion
5
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of NP and PA to provide office-based MAT such as Naltrexone and Buprenorphine yet, many of
these providers report not using them (Andrilla, Moore, Patterson and Larson, 2019). There are
notable barriers to effectively integrating MAT treatment into primary care setting. For example,
rural providers have noted the lack of mental health or psychosocial support as a barrier to
incorporating MAT into their practices (Andrilla, Coulthard and Patterson, 2018). Other barriers
waivered providers reported include lack of belief in agonist treatment, lack of time to see more
patients, and low reimbursement rates while non-waivered physicians cite diversion of
medication and managing numerous patients as reasons for not being waivered to treat OUD
(Huhn and Dunn, 2017). Studies have shown that to effectively implement OUD treatment and
increase MAT access in primary care, multidisciplinary and coordinated care delivery models are
essential (Lagisetty et al 2017).
EMS Providers:
As first responders, EMS providers see a high volume of drug overdose cases. Naloxone an
opioid antagonist that works to reverse the effect of the opioids are administered promptly during
such encounters. From 2012–2016, the rate of Emergency Medical Services (EMS) naloxone
administration events increased 75.1%, from 573.6 to 1004.4 administrations per 100,000 EMS
events (Cash et al, 2018). However, low administration of Naloxone has been reported in some
areas resulting from the difficulty in recognizing patient and scene characteristics in an overdose
event by EMS providers (Sumner et al, 2016). EMS providers are often the first line of contact
with individuals at particularly high risk for opioid related morbidity and mortality making them
uniquely situated to create critical linkages to treatment and supports for individuals with OUD.
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III.

Research Design

A review of literature provided background information that clarifies the roles of
providers and barriers they face in prescribing MAT for OUD. Although the primary care setting
serves as good place to implement OUD management, patients who are misusing opioids
sometime require emergency care from the emergency department or from first responders such
as EMS providers. The aim of this study is to identify the challenges these different provider
types encounter in the management of patients with OUD and the service/treatment gaps in York
County.
This capstone used data collected as part of the Rural York County Opioid Planning Project
to address the following research questions:
1. What treatment gaps exist in York County?
2. What are the challenges/barriers providers working in different clinical setting face in
treating OUD patients?
Location of Study
The location of the study is in York County which has the third highest rate of overdose
deaths in Maine. Data was gathered through providers focus groups which was conducted in five
different locations and an online survey sent to EMS providers working in York County.
Study Population
Participants in this study included medical providers currently working in organizations
located in York County Maine. The York consortium representatives identified providers within
their organization to participate in the focus groups and online survey.
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Recruitment email that provided information about the purpose of the study was sent to
each participant. For the online survey, the recruitment email contained a link that led to the
survey.
Protection of Human Subjects
A request for determination of research involving human subjects was sent to the office
of Research Integrity and Outreach at USM with background information about this study and
subsequently an IRB approval was obtained. In addition, before conducting each survey,
participants were informed about the purpose of the study and that participating was voluntary
after which an informed consent was obtained. Those participating in the focus group were
additionally informed that their responses will be recorded. Those who proceeded with the focus
group or online survey were believed to have given an informed consent. Both survey responses
were deidentified by removing all identifying properties in the reports generated from analysis of
the data
Data Collection:
This study used both qualitative and quantitative data collected as part of the Rural York
County Opioid Planning Project funded by HRSA. Data collection occurred from January 2019
to March of 2019. Data collection was done through regional providers’ focus groups, online
survey administered and using publicly available data sources.
1. Secondary Data: Existing data, including publicly available data from SAMHSA, CDC
and US Census Bureau was used to examine prevalence of OUD, provider capacity as
well as treatment and recovery services in York County.
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2. Providers Focus Group: Six regional focus groups with providers in York County was
conducted with providers in Biddeford, Kennebunk, Sanford, Springvale, Sacopee Valley
and Waterboro. Each lasted approximately 45 minutes and elicited responses from
providers on key topics of interest such as: managing OUD patients; barriers and
facilitators to implementing comprehensive prevention and treatment programs for OUD;
and gaps in services of OUD management (See Appendix 2 for focus group guide).
3. EMS Online Survey: This was administered online using the Snap Survey Tool. This
survey examined key domains including: opioid knowledge and attitudes, stigma, training
needs, barriers to managing the opioid crisis, and initiative fatigue among first responders.
It included open-ended response questions with a 5-point Likert- type scale ranging from
(1) “strongly agree” to (5) “strongly disagree” as end points and a middle score (3) “neither
agree nor disagree.” Low scores denoted positive conformity to a question whereas a high
score was associated with negative conformity (See Appendix 3 for EMS survey).
Data Analysis
Both quantitative and qualitative data were analyzed accordingly.
Quantitative Data Analysis: Data from the Snap survey tool was exported into SPSS software.
Descriptive statistics was then used to analyze the frequency and percentage to determine the
demographic distribution and response to each question.
Qualitative Data Analysis: Qualitative data from transcripts of providers’ focus groups and
open-ended responses from EMS surveys was systematically coded to derive high level themes.
Emerging themes and constructs that relate to this study such as barriers and treatment gaps was
compiled.
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Target Audience:
The key audience is the Rural York County Planning Consortium members (i.e.
representatives from Southern Maine Health Care (SMHC), Nasson Health Care, Maine
Behavioral Healthcare (MBH), Frannie Peabody Center (FPC), North East Mobile Health
Services (NEMHS) and the Kennebunk Police Department, (KPD). This capstone will inform
their current work on expanding access to MAT and increasing efficiency, integration and
coordination among and between service providers. Also, the results of the findings will be
relevant to a broader public health and health systems audience who are trying to address the
current Opioid crisis.
Limitation of Study Design:
The methods and data analytic strategies used to examine provider perspectives varied
between first responders and providers working in healthcare centers. While the qualitative data
from the focus group generated responses from providers based on open ended semi-structured
interview questions, the online survey of EMS providers contained largely Likert scale responses
with some opportunities for more in-depth responses through open-ended questions. While this is
a limitation of the study, both data collection strategies focused on gathering data on similar
domains and this was the most feasible way to get data from busy EMS providers. Also, all data
was self-reported and collected from individuals who agreed to participate in the study. This
means that their responses may not be generalizable to the broader group of first responders and
providers in York County.
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IV. Results
The data analysis resulted in identification of one primary theme reflecting the gaps in
treatment: essential treatment availability and four themes reflecting the challenges to managing
OUD in York County: access to care, inadequate workforce, stigma and patients engagement.
Also, demographic information describing the survey participants was included.
Demographics
PCP: Focus group was conducted in four different primary care setting with 35 providers
participating in them. The setting included 2 primary care clinics, 1 walk-in clinic and 1
behavioral health clinic in York County Maine. Among the participants, only 6 were waivered to
prescribe MAT with only 3 prescribing to patients.
ED Providers: One focus group was conducted for ED providers and had a total of 5 participants
including physicians (3) and Physician Assistant (2). None of the providers acknowledged they
are waivered to prescribe MAT to patients.
EMS Providers: Fifteen EMS providers completed the online survey. Majority of the
respondents were male (80%), have been employed for over 20 years (33%) and have EMS
license level of Paramedics (53%).
See table 1 below.

11

Challenges in OUD Management

Anumaka, 2019

Table 1: Demographic information of providers
Demographics

EMS Provider

PCP

ED Provider

# of participants

15 respondents

35 participants

5 participants

Gender

M = 80%
F = 20%

Not recorded

Not recorded

License type

Paramedics= 53%
Advanced EMT=27%
EMT Basic=20%

Physicians= 28%
NP=20%
BH=31%
PA=5%
RN=3%
Admin Staff = 11%

ED Physicians = 60%
PA= 40%

# waivered

Trained to administer
Naloxone

6 waivered with only 3
prescribing

None

Findings
1. Treatment Gaps: Essential Treatment Availability
Overall responses from all providers’ type show that most essential treatment services are
lacking in York County. Respondents identified four subthemes which includes: lack of
knowledge of how to access resources, detox centers, inadequate treatment services in primary
care settings and service shortage as gaps in treatment.
Lack of Knowledge of Resources
While 40% of EMS providers reported they were aware of treatment resources, both PCP and
ED providers were uncertain about resources for their patients as a provider shared: “The biggest
issue for me is just knowing how to access the correct resources.” In addition to this, all provider
types mentioned that patients are not adequately followed up due to the lack collaboration among
providers in the community.
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A provider noted in a statement that: “I thought about this a couple years ago but within our
community we didn't have adequate follow-up. I didn't have any resources within my community
to connect people with treatment beyond MAT. At least a couple of years ago and until now, I
didn't feel my patients would have the therapy that they needed. There was no point in me
prescribing Suboxone to somebody if they were not going to be followed up in a responsible way,
I felt. Then I just haven’t done it since then. I don't feel there is a really big need for me to do
that right now. I don't know how much it would benefit my patients to put that extra time in.”
Most providers noted that since they are unaware of treatment resources and do not get feedback
for patients they refer for mental health care, it affects their clinical decision when managing
OUD patients.

Inadequate Treatment Services in Primary Care
PCP providers noted that in most primary care settings, OUD treatment services are either not
offered or are inadequate as described by a provider: “ The fact that we don’t offer it in primary
care, that’s a gap. Or it’s not readily available in primary care as it could be. I haven’t seen
enough patients to know.” This inadequacy in the primary setting can also be attributed to the
limited number of waivered prescribers in York County.

Service Shortage
Similar responses among all provider type mentioned service shortage as a current gap within the
service systems that is not yet addressed. Services such as mental and behavioral health services,
detox centers and pharmacies to fill prescriptions were among notable services lacking in York
County.
13
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The closest detox center to York County is far away in Portland and is not easily accessible for
patients. One provider noted: “The biggest gap is the only one that does it is Milestone in
Portland and almost none of my patients can get a ride there.” In addition to this the PCPs noted
the importance of having community wrap around services that is needed as a preventive service
for pain management.

2. Challenges: Access to Care:
Majority of EMS providers (66%) reported that there were few barriers for people trying to
access treatment for OUD unlike the PCP and ED Providers who believed York County has
barriers that affect patients’ access to treatment. The high-level sub-themes derived from their
responses include: transportation and financial barrier (prescription cost and insurance coverage).

Transportation:
Transportation is needed for patients to travel to treatment site, unfortunately in York County
there are no adequate transportation system and most patient do not have cars making it difficult
for them to get to the clinic. This was a problem echoed by both PCP and ED provider as a major
barrier. A provider summarized a patient’s complaint: “My friend had a car today, so this is how
I got here.” There’s so many barriers out here, like you said, just how rural we are. How do you
get there? Pay for the gas to get there?” Providers noted that they are time crunched and will prefer
patients arriving on time for their appointments. The lack of transportation and distance of treatment
centers discourages providers from referring or managing such patients.
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Financial Barrier:
Both PCP and ED providers reported that the high cost of medication and lack of insurance
coverage was a major challenge for patients to access treatment. A statement that summarized
this by a provider was thus: “Yeah, anyone can come here regardless of insurance or not, but
they can't always pay for the medication.” And provider another noted: “Seeing a counselor,
provider to prescribe, then the cost of medication itself is expensive. That is a big one” Providers
also noted that they are unaware of the cost or insurance coverage for OUD treatment and cannot
provide such information to patients. Inability of patients to pay for these medications influences
their adherence to treatment.

3.

Challenges: Stigma

All provider types acknowledged that stigma is associated with drug use and can affect how care
is rendered in different care setting and how people are treated in the community. For example,
patients living in Halfway houses can lose their housing because taking MAT is not considered
soberness. A provider reported this about a patient who was at the verge of losing housing: “One
thing that recently came up for me was I have a patient living in a halfway house and they
wouldn’t allow him to take Suboxone while he was living in a halfway house. Between myself
and his social worker we were able to convince the person running the halfway house that if he
didn't do this he was going to use. The person running the halfway house felt that wasn’t a good
alternative.” Also, stigma among providers who believe that the patients are intentionally
harming themselves was summarized thus: “there are still pockets of stigma of they're doing this
to themselves and why do we keep resuscitating them when they come in in respiratory cardiac
arrest. There is still some of that out there and it’s a constant push to try to overcome it.”
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Overall, providers believed that education about OUD can help to eliminate stigma in healthcare
settings and the community.

4.

Challenges: Inadequate Workforce Capacity

Most providers mentioned that their workforce capacity was not enough in providing necessary
treatment for OUD. Two subthemes cited were: staff shortage and training needs.

Staff Shortage
Although EMS providers noted they were adequately staffed, they reported being fatigued from
the large volume of overdose related calls. Meanwhile, both PCP and ED providers mentioned
that given the amount of time needed to see patients coupled with the limited number of
dedicated staffs such as case managers, nurses, and recovery coaches it was difficult to manage
OUD. A provider summarized this by saying: “In most places some people wear many
hats…and there is just little time to focus on treating MAT patients.” The providers went further
highlighting the importance of having dedicated staff who can help patients to find resources for
treatment and follow up with them to ensure they are getting the care they need.

Training Needs
While majority of EMS providers (87%) reported that they are adequately trained to identify and
manage overdose symptoms, majority of PCP and ED providers mentioned they need more
training on how to manage OUD, how to get waivered and information about referral resources
in the community.
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An EMS provider stated: “we need very little training, we have been bombarded by this…we
know how to manage overdose patients. We need more resources.” In addition, the PCP and ED
providers who mentioned they need more training noted that they will prefer training that are not
time consuming and is customized to fit their busy schedules. The long training hours required
for getting waivered was a deterrent for those who are not waivered.

5. Challenges: Patient Engagement in Treatments
Patient’s resistance or denial of OUD condition was a notable response from all provider types.
Among the EMS providers, they noted that people do not call 911 during an emergency and most
times refuse administration of Narcan. As an EMS provider noted “…the challenge when Narcan
is given and the patient then has the right to sign off even though in my opinion they are not
competent as the drug is still in their system, but according to MEMS and the on line medical
control physicians, they have that right as they technically are alert and oriented at that time
although there is always the potential that the Narcan will wear off (due to the short half-life”
Similarly, PCP noted that most OUD patients deny their conditions, and some do not keep to
their appointments which they believed might be due to the time of the day for their appointment
conflicting with their work or child care. Furthermore, an ED provider gave this summary of the
difficulty in keeping patients engaged: “It takes a commitment. That’s huge. It’s just very hard to
keep them engaged in the treatment.” According to the providers, patients need support from
their community and families in order to continue treatment. Most patients who do not have
these sometimes relapse. Although this is beyond the providers intervention, they believe that
eliminating environmental triggers such as street drugs will be helpful for engaging patients.
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V.

Discussion

The recent rise in opioid related deaths in many rural areas compared to urban areas has
become a major public health concern (Mack et al, 2017). This is the case in rural York County
where increase in overdose deaths has been reported in the past years. Also, given that it is
designated as a health care provider shortage area calls for quick intervention. This study
revealed the gaps in treatment resources and challenges providers working in different clinical
setting in York County face in managing OUD. Among the responses gathered from all provider
types, it is apparent that lack of essential treatment resources, access to care, stigma, inadequate
workforce capacity and patient engagement in treatment are major barriers to managing OUD.
Similar responses among all providers that highlight major concerns that must be
addressed in order to improve OUD treatment in York County include: stigma, inadequate
workforce capacity, patients’ engagement and limited treatment resources. Like York County,
most rural areas do not have adequate workforce, mental and behavioral services (RHIhub, 2019)
and detox centers that are close by (Lenardson, et al 2009). Also, stigma was a notable barrier
across all provider types. Stigma emanates from the language used for addiction, set policies,
treatment setting (Wakeman &Rich, 2018), belief that addiction is a willful choice, and the
separation of OUD treatment from the rest of the medical system (Olsen, et al 2014). However,
providers believed that this can be overcome by educating providers and community members
about the causes of OUD. Furthermore, engaging patients in treatment was a major barrier
identified across all provider types. Patient refusal to be treated either during an overdose
emergency or in an office setting was attributed to state laws and no shows. This is a major
concern in addressing the high rate of overdose deaths occurring in the entire state.
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Also, there was notable difference in the training needs reported by providers. While
majority of EMS providers reported they have enough training and knowledge of OUD resources
within the community, most PCP and ED providers had major concerns about their lack of
knowledge of both prescription cost and treatment resources within the community. This was a
major finding of this study as it highlights an immediate need to inform providers about OUD
resources that are located around their practice area. Another significant difference in providers
response was their answers to the barriers people face in accessing treatment. While more than
half of EMS providers reported that there were few barriers to accessing treatment, both PCP and
ED providers overwhelmingly noted that inadequate transportation and financial constraints
contributed to their inability to manage patients with OUD.
Overall responses among the ED providers reveal that they are interested in engaging OUD
patients’ in treatments but will require more information about OUD resources within the
community and how to get waivered. This is different from a study that identified ED Providers’
perception of buprenorphine as a substitution to another drug as a barrier to prescribing in ED
setting (Cisewski et al, 2018). Also, while this study revealed that EMS Providers in York
County are adequately trained to identify and manage an overdose situation, a different study
revealed that EMS Providers inability to identify an overdose, was a major barrier to managing
overdose patients (Sumner et al, 2016). However, the barriers identified by the PCP in this study
such as inadequate staffing, training needs, stigma (Storholm et al 2017, Jones et al 2019 and
Haffajee et al 2018) lack of mental health services (Andrilla, Coulthard and Patterson, 2018), and
time constraints from seeing patients (Huhn & Dunn, 2017) were similar finding in other primary
care setting.
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VI. Recommendations
Based on responses from providers, the following suggestion will help alleviate the identified
provider level challenges in York County:
•

Trainings: tailored trainings that fits into providers busy schedule is recommended. These
training can be delivered in different format including online or in person training.

•

Staffing: Recruitment and retention of dedicated staff such as case managers and
recovery coaches and training of existing staff on OUD management can help bridge the
staffing shortage. Also, these staff can work with providers and patients to provide
relevant information about accessible treatments.

•

Stigma: Educating providers, staff and community members about OUD causes and
dangers of stigma for patients

•

Improve collaboration : Most providers noted inadequate follow up and lack of
knowledge of OUD resources as a barrier. This can be improved by increasing
collaboration across different organizations.

•

Increase access to OUD treatment: Incentivizing more providers to get waivered and
prescribe MAT is a crucial solution for York County. Having more waivered prescribers
and behavioral/mental providers would also reduce the travel time for patients to access
treatment within the community.

•

Monitoring: Tracking the progress of established OUD programs such as the HUB and
Spoke model to ensure continuous performance improvement is crucial. Also,
maintaining proper implementation of the prescription monitoring program to ensure
adherence to evidence-based prescription practice in the ED and Primary care settings.
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VII. Conclusion
This study identified several factors that needs to be addressed in order to decrease the high
rate of overdose deaths in York County. As different strategies to curb down the prevalence of
overdose deaths emerge, this study can inform the ongoing efforts of increasing efficiency and
collaboration among providers and expanding MAT for OUD treatment. Also, it highlights the
need to improve treatment resources, staff recruitment and provider training particularly ED and
PCP. As well, all providers will benefit by learning how to eliminate stigma that arise during
encounter with patients.
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Appendix 1
Capstone Integration with Muskie School of Public Service MPH Program
MPH Competency

Relevant Course Work

Capstone Application

•

MPH 650 Applied Public
Health Research and
Evaluation

•

Literature reviews

•

Focus group and
survey

•

In making
recommendations

•

Data analysis

•

Literature reviews
and
recommendations

•

Secondary data
analysis

•

Study design

•

Data analysis

•

Interpretation of
survey and focus
group results

Critically evaluate
epidemiological studies
and literature

•

Identify organizational
and community concerns,
assets and deficit.

•

Apply evidence-based
principles and knowledge
to decision making

•

Use data to inform public
health decision making

•

Describe determinants of
health, incorporate
evidence and tools to
inform public health
practice

MPH 565 Social and
Behavioral Health

Statistical analysis and
interpretation of results

MPH 435/535 Introduction
to Epidemiological
Research and MPH 545
Applied Biostatistical
Analysis

•

•

Develop work plan and
timeline

MPH 630 Health Planning
and Marketing

Preparation od workplan
and time line

•

Demonstrate written and
oral skills with diverse
audience

Capstone

Capstone draft and
presentation
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Appendix 2
Provider Focus Group Questionnaire

27

Challenges in OUD Management

Anumaka, 2019

Provider Focus Group Questionnaire
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Appendix 3
EMS Online Survey Questionnaire
•

I am confident in how to recognize an apparent drug overdose as it differs from
other medical emergencies, such as a diabetic coma.

•

I am going to need more training before I would feel confident to help someone who
had overdosed.

•

There are few barriers for people trying to access treatment for opioid use disorder.

•

In my work, I am aware of community resources for people struggling with opioid
use disorder.

•

What barriers existing for EMS staff in responding to and managing individuals
with opioid use disorder?

•

What resources do EMS staff and organizations need to effectively address opioid
use disorder in your community?

•

What types of education and training on opioid use disorder are needed for EMS
staff?
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